HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sensitization to Anisakis simplex species in the population of northern Morocco.

AbstractOBJECTIVE:
To investigate sensitization to third-stage Anisakis simplex larvae in a randomly selected population in northern Morocco.
METHODS:
We studied sera obtained from clinical analysis laboratories in Tangier and Tetuouan and from fishermen at Tangier port. The age of the study population ranged from 6 to 83 years. ImmunoCAP and immunoblotting techniques were used to determine total and specific immunoglobulin (Ig) E values and the chi2 and Fisher exact tests were applied to analyze relationships between study variables.
RESULTS:
A seroprevalence of 5.1% was found, with a higher percentage of positive sera in the 31-to-43-year age group. Sensitization was not significantly associated with the origin, sex, occupation, or age of the individuals studied. In sera positive by InmunoCAP, immunoblotting studies detected numerous bands of between 7 kDa and >209 kDa, with a predominance of bands in the approximately 20-kDa to 24-kDa range.
CONCLUSIONS:
Although no cases of human anisakiasis have been reported in Morocco to date, part of a randomly selected population in Northern Morocco shows sensitization to A simplex proteins.
AuthorsN Abattouy, A Valero, J Martín-Sánchez, M C Peñalver, J Lozano
JournalJournal of investigational allergology & clinical immunology (J Investig Allergol Clin Immunol) Vol. 22 Issue 7 Pg. 514-9 ( 2012) ISSN: 1018-9068 [Print] Spain
PMID23397674 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Helminth
  • Immunoglobulin E
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Anisakis (immunology)
  • Antibodies, Helminth (blood, immunology)
  • Child
  • Female
  • Humans
  • Hypersensitivity (blood, epidemiology)
  • Immunoblotting
  • Immunoglobulin E (blood, immunology)
  • Male
  • Middle Aged
  • Morocco (epidemiology)
  • Seroepidemiologic Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: